The global immunochemistry reagents, analysers and test kits market will reach $18.1 billion in 2015

Wednesday 15 May 2013, Amsterdam

A new report predicts that the global market for immunochemistry reagents, analysers and test kits will reach $18.1bn in 2015. That revenue forecast and others appear in Immunochemistry Reagents, Analysers and Test Kits: World Market 2013-2023, published in March 2013.

We predict the immunochemistry market will experience strong growth, driven by an increase in demand for diagnostic testing. This demand, along with increased research activity for identifying new analytes, will be driven by an aging global population and technological advances. The Immunochemistry market is one of the largest sectors of the global in vitro diagnostics (IVD) market. This sector encompasses all reagents, instruments and test kits to conduct diagnoses outside the living organism.

Amritha.M.Ramakrishnan, healthcare industry analyst says “As a mature sector of the IVD market, growth will be steady and continuous. Due to the maturity of the market, clinicians are likely to opt for immunochemistry products over other new technologies. High incidences of cancer, infectious diseases and cardiovascular diseases, along with a global aging population will fuel demand for immunochemistry based tests. The immunochemistry market will also benefit from strong growth in emerging countries, as these markets remain relatively under penetrated. Countries like China and India offer huge opportunities, especially due to their vast patient population.

“Despite the market being dominated by a few large medical device manufacturers, there are several small companies manufacturing niche and innovative products. Market growth will be driven by an increasing demand for automated systems, especially from developing nations. The most obvious benefit of increasing automation is the reduction of human error and overall costs. Automation has become important in the context of budget restriction and staff reduction. However, the immunochemistry diagnostic market will face increasing competition from other diagnostic technologies and so, future growth will depend on the availability of more clinical evidence to prove effectiveness of immunochemistry tests. The increasing competition from other technologies will also require market participants to differentiate their products to remain competitive.”

Our report gives revenue forecasts to 2023 at overall world market, submarket and national level.

It forecasts world sales for the following submarkets:

• Immunochemistry reagents and tests kits
• Immunochemistry analysers

The study also forecasts immunochemistry reagents and tests kits subsectors

• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests

That investigation includes analyses of six leading companies, including Roche, Siemens Healthcare, Abbott, Danaher, Ortho Clinical Diagnostics (J&J) and bioMérieux.

The study includes researching trends and forecasting revenues in leading national markets. Countries analysed are the US, Japan, Germany, France, the UK, Spain, Italy, India and China. The analysis also discusses opportunities and developments – technological and commercial.

Immunochemistry Reagents, Analysers and Test Kits: World Market 2013-2023 adds to visiongain’s range of analytical reports on industries and markets in healthcare.